Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma

Clinical trial NCT05324384 · UNKNOWN

Trial details

NCT number: NCT05324384
Sponsor: West China Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hemangioendothelioma

Start date: 2022-04-05
Primary completion: 2025-04-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.